Recerca
Àrea 2
Investigació aplicada en malalties respiratòries infeccioses, malalt crític i càncer de pulmó
Factor d'impacte: mitjana: 5.25, total: 330.97
Articles de l'any 2010
Original
-
Validation of the American Thoracic Society-Infectious Diseases Society of America Guidelines for Hospital-Acquired Pneumonia in the Intensive Care Unit
Ferrer M, Liapikou A, Valencia M, Esperatti M, Theessen A, Martinez JA, Mensa J, Torres A
CLIN INFECT DIS. 2010; 50: 945-952. IF: 8.195 -
Nursing home-acquired pneumonia: a 10 year single-centre experience
Polverino E, Dambrava P, Cilloniz C, Balasso V, Marcos MA, Esquinas C, Mensa J, Ewig S, Torres A
THORAX. 2010; 65: 354-359. IF: 7.041 -
Macrophage activation in exacerbated COPD with and without community-acquired pneumonia
Gutierrez P, Closae D, Piner R, Bulbena O, Menendez R, Torres A
EUR RESPIR J. 2010; 36: 285-291. IF: 5.527 -
Development and validation of the Capacity of Daily Living during the Morning questionnaire and the Global Chest Symptoms Questionnaire in COPD
Partridge MR, Miravitlles M, Stahl E, Karlsson N, Svensson K, Welte T
EUR RESPIR J. 2010; 36: 96-104. IF: 5.527 -
What lessons have been learnt from animal models of MRSA in the lung?
Martinez-Olondris P, Rigol M, Torres A
EUR RESPIR J. 2010; 35: 198-201. IF: 5.527 -
TB or not TB: update from the ERS Respiratory Infection Assembly 10
Miravitlles M, Ferrara G, Lange C, Dimopoulos G, Rohde G, Blasi F, Migliori GB
EUR RESPIR J. 2010; 36: 665-670. IF: 5.527 -
Serotype-specific pneumococcal disease may be influenced by mannose-binding lectin deficiency
Valles X, Roca A, Lozano F, Morais L, Suarez B, Casals F, Mandomando I, Sigauque B, Nhalungo D, Esquinas C, Quinto L, Alonso PL, Torres A
EUR RESPIR J. 2010; 36: 856-863. IF: 5.527 -
An experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated piglets
Martinez-Olondris P, Sibila O, Agusti C, Rigol M, Soy D, Esquinas C, Piner R, Luque N, Guerrero L, Quera MA, Marco F, DeLaBellacasa JP, Ramirez J, Torres A
EUR RESPIR J. 2010; 36: 901-906. IF: 5.527 -
Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997-2007
Soriano JB, Ancochea J, Miravitlles M, Garcia-Rio F, Duran-Tauleria E, Munoz L, Jimenez-Ruiz CA, Masa JF, Viejo JL, Villasante C, Fernandez-Fau L, Sanchez G, Sobradillo-Pena V
EUR RESPIR J. 2010; 36: 758-765. IF: 5.527 -
Laboratory testing of individuals with severe alpha(1)-antitrypsin deficiency in three European centres
Miravitlles M, Herr C, Ferrarotti I, Jardi R, Rodriguez-Frias F, Luisetti M, Bals R
EUR RESPIR J. 2010; 35: 960-968. IF: 5.527 -
Inhaled drugs as risk factors for community-acquired pneumonia
Almirall J, Bolibar I, Serra-Prat M, Palomera E, Roig J, Hospital I, Carandell E, Agusti M, Ayuso P, Estela A, Torres A
EUR RESPIR J. 2010; 36: 1080-1087. IF: 5.527 -
Patients' characterization, hospital course and clinical outcomes in five Italian respiratory intensive care units
Polverino E, Nava S, Ferrer M, Ceriana P, Clini E, Spada E, Zanotti E, Trianni L, Barbano L, Fracchia C, Balbi B, Vitacca M
INTENS CARE MED. 2010; 36: 137-142. IF: 5.168 -
Daptomycin Is Effective for Treatment of Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus epidermidis
Garcia-De-La-Maria C, Marco F, Armero Y, Soy D, Moreno A, DelRio A, Almela M, Cervera C, Ninot S, Falces C, Mestres CA, Gatell JM, DeAnta MTJ, Miro JM
ANTIMICROB AGENTS CH. 2010; 54: 2781-2786. IF: 4.802 -
Tolerance of Benznidazole in Treatment of Chagas' Disease in Adults
Pinazo MJ, Munoz J, Posada E, Lopez-Chejade P, Gallego M, Ayala E, DelCacho E, Soy D, Gascon J
ANTIMICROB AGENTS CH. 2010; 54: 4896-4899. IF: 4.802 -
Treatment of acute cough/lower respiratory tract infection by antibiotic class and associated outcomes: a 13 European country observational study in primary care
Butler CC, Hood K, Kelly MJ, Goossens H, Verheij T, Little P, Melbye H, Torres A, Molstad S, Godycki-Cwirko M, Almirall J, Blasi F, Schaberg T, Edwards P, Rautakorpi UM, Hupkova H, Wood J, Nuttall J, Coenen S
J ANTIMICROB CHEMOTH. 2010; 65: 2472-2478. IF: 4.352 -
Common Variants of TLR1 Associate with Organ Dysfunction and Sustained Pro-Inflammatory Responses during Sepsis
Pino-Yanes M, Corrales A, Casula M, Blanco J, Muriel A, Espinosa E, Garcia-Bello M, Torres A, Ferrer M, Zavala E, Villar J, Flores C
PLOS ONE. 2010; 5: 0-0. IF: 4.351 -
Procalcitonin and C-Reactive Protein for Invasive Bacterial Pneumonia Diagnosis among Children in Mozambique, a Malaria-Endemic Area
Diez-Padrisa N, Bassat Q, Machevo S, Quinto L, Morais L, Nhampossa T, O'callaghan-Gordo C, Torres A, Alonso PL, Roca A
PLOS ONE. 2010; 5: 0-0. IF: 4.351 -
Effects of heated humidification on nasal inflammation in a CPAP rat model
Martinez-Vidal B, Farre R, Montserrat JM, Torres M, Almendros I, Aguilar F, Embid C, Vilaseca I
SLEEP MED. 2010; 11: 413-416. IF: 3.699 -
Systemic inflammation in chronic obstructive pulmonary disease: a population-based study
Garcia-Rio F, Miravitlles M, Soriano JB, Munoz L, Duran-Tauleria E, Sanchez G, Sobradillo V, Ancochea J
RESP RES. 2010; 11: 0-0. IF: 3.127 -
Colour of sputum is a marker for bacterial colonisation in chronic obstructive pulmonary disease airway
Miravitlles M, Marin A, Monso E, Vila S, DeLaRoza C, Hervas R, Esquinas C, Garcia M, Millares L, Morera J, Torres A
RESP RES. 2010; 11: 0-0. IF: 3.127 -
Obstructive apneas induce early activation of mesenchymal stem cells and enhancement of endothelial wound healing
Carreras A, Rojas M, Tsapikouni T, Montserrat JM, Navajas D, Farre R
RESP RES. 2010; 11: 0-0. IF: 3.127 -
Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial
Sethi S, Jones PW, Theron MS, Miravitlles M, Rubinstein E, Wedzicha JA, Wilson R
RESP RES. 2010; 11: 0-0. IF: 3.127 -
Changes in oxygen partial pressure of brain tissue in an animal model of obstructive apnea
Almendros I, Montserrat JM, Torres M, Gonzalez C, Navajas D, Farre R
RESP RES. 2010; 11: 0-0. IF: 3.127 -
Validation and comparison of SCAP as a predictive score for identifying low-risk patients in community-acquired pneumonia
Espana PP, Capelastegui A, Quintana JM, Bilbao A, Diez R, Pascual S, Esteban C, Zalacain R, Menendez R, Torres A
J INFECTION. 2010; 60: 106-113. IF: 3.06 -
Prevalence of dihydropteroate synthase genotypes before and after the introduction of combined antiretroviral therapy and their influence on the outcome of Pneumocystis pneumonia in HIV-1-infected patients
Alvarez-Martinez MJ, Miro JM, Valls ME, Mas J, DeLaBellacasa JP, Sued O, Sole M, Rivas PV, DeLazzari E, Benito N, Garcia F, Agusti C, Wilson PE, Gatell JM, DeAnta MTJ, Meshnick SR, Moreno A
DIAGN MICR INFEC DIS. 2010; 68: 60-65. IF: 2.451 -
Bronchiectasis in primary Sjogren's syndrome: prevalence and clinical significance
Soto-Cardenas MJ, Perez-De-Lis M, Bove A, Navarro C, Brito-Zeron P, Diaz-Lagares C, Gandia M, Akasbi M, Siso A, Ballester E, Torres A, Ramos-Casals M
CLIN EXP RHEUMATOL. 2010; 28: 647-653. IF: 2.396 -
Changes in management of chronic obstructive pulmonary disease (COPD) in primary care: EMMEPOC study
Soler N, Ballester E, Martin A, Gobartt E, Miravitlles M, Torres A
RESP MED. 2010; 104: 67-75. IF: 2.331 -
Predictive accuracy of the pneumonia severity index vs CRB-65 for time to clinical stability: Results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study
Arnold FW, Brock GN, Peyrani P, Rodriguez EL, Diaz AA, Rossi P, Ramirez JA
RESP MED. 2010; 104: 1736-1743. IF: 2.331 -
Clinical outcomes of HIV-infected patients hospitalized with bacterial community-acquired pneumonia
Malinis M, Myers J, Bordon J, Peyrani P, Kapoor R, Nakamatzu R, Lopardo G, Torres A, Feldman C, Allen M, Arnold F, Ramirez J
INT J INFECT DIS. 2010; 14: 0-0. IF: 2.167 -
Geographical Variations in the Prevalence of COPD in Spain: Relationship to Smoking, Death Rates and other Determining Factors
Soriano JB, Miravitlles M, Borderias L, Duran-Tauleria E, Rio FG, Martinez J, Montemayor T, Munoz L, Pineiro L, Sanchez G, Serra J, Soler-Cataluna JJ, Torres A, Viejo JL, Sobradillo-Pena V, Ancochea J
ARCH BRONCONEUMOL. 2010; 46: 522-530. IF: 2.166 -
Mesenchymal stem cells reduce inflammation in a rat model of obstructive sleep apnea
Carreras A, Almendros I, Montserrat JM, Navajas D, Farre R
RESP PHYSIOL NEUROBI. 2010; 172: 210-212. IF: 2.135 -
Rethinking the concepts of community-acquired and health-care-associated pneumonia
Ewig S, Welte T, Chastre J, Torres A
LANCET INFECT DIS. 2010; 10: 279-287. IF: 15.583 -
Continuous positive airway pressure as treatment for systemic hypertension in people with obstructive sleep apnoea: randomised controlled trial
Duran-Cantolla J, Aizpuru F, Montserrat JM, Ballester E, Teran-Santos J, Aguirregomoscorta JI, Gonzalez M, Lloberes P, Masa JF, DeLaPena M, Carrizo S, Mayos M, Barbe F
BRIT MED J. 2010; 341: 0-0. IF: 13.66 -
Long-term Effect of Continuous Positive Airway Pressure in Hypertensive Patients with Sleep Apnea
Barbe F, Duran-Cantolla J, Capote F, DeLaPena M, Chiner E, Masa JF, Gonzalez M, Marin JM, Garcia-Rio F, DeAtauri JD, Teran J, Mayos M, Monasterio C, DelCampo F, Gomez S, DeLaTorre MS, Martinez M, Montserrat JM
AM J RESP CRIT CARE. 2010; 181: 718-726. IF: 10.689 -
Update in Community-acquired and Nosocomial Pneumonia 2009
Torres A, Rello J
AM J RESP CRIT CARE. 2010; 181: 782-787. IF: 10.689 -
Nosocomial Pneumonia in the Intensive Care Unit Acquired by Mechanically Ventilated versus Nonventilated Patients
Esperatti M, Ferrer M, Theessen A, Liapikou A, Valencia M, Saucedo LM, Zavala E, Welte T, Torres A
AM J RESP CRIT CARE. 2010; 182: 1533-1539. IF: 10.689 -
Sleep Breathing Flow Characteristics as a Sign for the Detection of Wakefulness in Patients with Sleep Apnea
Guerrero A, Embid C, Farre R, Navajas D, Masa JF, Duran J, Montserrat JM
RESPIRATION. 2010; 80: 495-499. IF: 1.935 -
Development and validation of a high performance liquid chromatography method to determine linezolid concentrations in pig pulmonary tissue
Guerrero L, Martinez-Olondris P, Rigol M, Esperatti M, Esquinas C, Luque N, Piner R, Torres A, Soy D
CLIN CHEM LAB MED. 2010; 48: 391-398. IF: 1.886 -
Predicting bacteremic pneumonia in HIV-1-infected patients consulting the ED
Perello R, Miro O, Marcos MA, Almela M, Bragulat E, Sanchez M, Agusti C, Miro JM, Moreno A
AM J EMERG MED. 2010; 28: 454-459. IF: 1.542
Revisió
-
Do guidelines change outcomes in ventilator-associated pneumonia?
Bassi GL, Ferrer M, Saucedo LM, Torres A
CURR OPIN INFECT DIS. 2010; 23: 171-177. IF: 4.723 -
Short-course fluoroquinolone therapy in exacerbations of chronic bronchitis and COPD
Anzueto A, Miravitlles M
RESP MED. 2010; 104: 1396-1403. IF: 2.331 -
Sleep Apnea-Hypopnea Syndrome in the Elderly
Martinez-Garcia MA, Duran-Cantolla J, Montserrat JM
ARCH BRONCONEUMOL. 2010; 46: 479-488. IF: 2.166 -
Extracorporeal Lung Assist in Severe Respiratory Failure and ARDS. Current Situation and Clinical Applications
Gomez-Caro A, Badia JR, Ausin P
ARCH BRONCONEUMOL. 2010; 46: 531-537. IF: 2.166 -
Usefulness of Macrolides as Anti-Inflammatories in Respiratory Diseases
Sevilla-Sanchez D, Soy-Muner D, Soler-Porcar N
ARCH BRONCONEUMOL. 2010; 46: 244-254. IF: 2.166
Editorials
-
Severity scores for CAP. 'Much workload for the next bias'
Ewig S, Torres A
THORAX. 2010; 65: 853-855. IF: 7.041 -
Enterobacteriaceae and Pseudomonas aeruginosa in community-acquired pneumonia: the reality after a decade of uncertainty?
Torres A, Menendez R
EUR RESPIR J. 2010; 35: 473-474. IF: 5.527 -
Non-Invasive Mechanical Ventilation and the Prognosis in Chronic Obstructive Pulmonary Disease
Ferrer M
ARCH BRONCONEUMOL. 2010; 46: 399-401. IF: 2.166 -
VAP surveillance: role of non-quantitative culture of endotracheal aspirates (NQC-ETA)
Polverino E, Ferrer M
MINERVA ANESTESIOL. 2010; 76: 572-574. IF: 1.614
Multicèntrics
-
A Randomized Study of Endobronchial Valves for Advanced Emphysema
Sciurba FC, Ernst A, Herth FJF, Strange C, Criner GJ, Marquette CH, Kovitz KL, Chiacchierini RP, Goldin J, Mclennan G
NEW ENGL J MED. 2010; 363: 1233-1244. IF: 47.05
Guies clíniques
-
Community Acquired Pneumonia. New Guidelines of the Spanish Society of Chest Diseases and Thoracic Surgery (SEPAR)
Menendez R, Torres A, Aspa J, Capelastegui A, Prat C, DeCastro FR
ARCH BRONCONEUMOL. 2010; 46: 543-558. IF: 2.166